2019
DOI: 10.1164/rccm.201806-1135oc
|View full text |Cite
|
Sign up to set email alerts
|

Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
76
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
4
1

Relationship

2
7

Authors

Journals

citations
Cited by 109 publications
(81 citation statements)
references
References 46 publications
5
76
0
Order By: Relevance
“…Details regarding the PCR amplification of the 16S rRNA gene V4 region were previously reported [27]. The cecal microbiome was determined by polymerase chain reaction (PCR) amplification of the 16S rRNA gene V4 region using the Illumina MiSeq 1 platform (2 x 250 bp) [28].…”
Section: Microbiome Profilingmentioning
confidence: 99%
“…Details regarding the PCR amplification of the 16S rRNA gene V4 region were previously reported [27]. The cecal microbiome was determined by polymerase chain reaction (PCR) amplification of the 16S rRNA gene V4 region using the Illumina MiSeq 1 platform (2 x 250 bp) [28].…”
Section: Microbiome Profilingmentioning
confidence: 99%
“…The airway microbiome in chronic obstructive pulmonary disease (COPD) has been well studied in the last decade. The airway microbiome differs between health and COPD[13], shifts during exacerbations[46], associates with airway inflammation[5, 7] and predicts 1-year mortality of hospitalized exacerbation patients[8], all suggesting the implication of airway microbiome in COPD pathogenesis. Despite advances, the precise role of airway microbiome in COPD remains incompletely understood.…”
Section: Introductionmentioning
confidence: 99%
“…provided a state‐of‐the‐art review, describing the methods, the potential application and limitations of current molecular techniques to interrogate the lower airway microbiome in COPD . Although the airway microbiome may have a broad‐ranging impact in COPD patients, clinical translation of these techniques is closest in the setting of acute exacerbations where airway microbiome research has unveiled sputum microbial markers of mortality following hospitalizations . In one study, the presence of Staphylococcus species (which are pathogens in airways) and the absence of Veillonella species, which are normal commensals in the airways, were associated with a >10‐fold increase in the risk of 1‐year mortality .…”
Section: Emerging Areas In the Era Of ‘Omics’mentioning
confidence: 99%
“…Although the airway microbiome may have a broad‐ranging impact in COPD patients, clinical translation of these techniques is closest in the setting of acute exacerbations where airway microbiome research has unveiled sputum microbial markers of mortality following hospitalizations . In one study, the presence of Staphylococcus species (which are pathogens in airways) and the absence of Veillonella species, which are normal commensals in the airways, were associated with a >10‐fold increase in the risk of 1‐year mortality . In the near future, the airway microbiome may become a treatable trait in COPD.…”
Section: Emerging Areas In the Era Of ‘Omics’mentioning
confidence: 99%